Analysts Set Teleflex Incorporated (NYSE:TFX) PT at $182.63

Shares of Teleflex Incorporated (NYSE:TFX) have been given an average recommendation of “Hold” by the eleven ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $182.63.

TFX has been the subject of a number of research analyst reports. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and cut their price target for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. Truist Financial lowered their price objective on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research note on Monday, March 3rd. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Finally, Wells Fargo & Company lowered their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th.

Teleflex Stock Down 2.4 %

Shares of NYSE TFX opened at $135.46 on Monday. The firm has a market cap of $6.28 billion, a P/E ratio of 26.93, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex has a 1 year low of $128.55 and a 1 year high of $249.90. The firm’s 50 day moving average price is $168.73 and its 200 day moving average price is $199.15.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. As a group, sell-side analysts anticipate that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.00%. Teleflex’s dividend payout ratio (DPR) is currently 95.77%.

Hedge Funds Weigh In On Teleflex

Several hedge funds and other institutional investors have recently bought and sold shares of TFX. Siemens Fonds Invest GmbH acquired a new stake in Teleflex in the fourth quarter valued at approximately $1,336,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Teleflex during the 4th quarter valued at $6,528,000. Jefferies Financial Group Inc. increased its stake in Teleflex by 9.3% during the 4th quarter. Jefferies Financial Group Inc. now owns 4,837 shares of the medical technology company’s stock worth $861,000 after buying an additional 412 shares during the period. Mackenzie Financial Corp lifted its holdings in Teleflex by 59.2% in the 4th quarter. Mackenzie Financial Corp now owns 36,281 shares of the medical technology company’s stock worth $6,457,000 after buying an additional 13,488 shares in the last quarter. Finally, Forum Financial Management LP boosted its position in Teleflex by 48.6% in the 4th quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company’s stock valued at $230,000 after buying an additional 423 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.